Twist Bioscience Corporation (TWST)
$151.33-0.35%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.4B
- Beta
- 2.19
- P/E (TTM)
- -68.17
- Short % float
- 17.70%
- Days to cover
- 3.8
- SI change
- -15.5%
- 1W
- -9.37%
- 1M
- +12.30%
- vs SPY 1W
- -9.23%
- vs SPY 1M
- +9.80%
Industry peers
FMP comparable companies · ranked by market cap
- 207940.KSSamsung Biologics Co.,Ltd.$56.4T$1219000.00
- WUXIFWuXi AppTec Co., Ltd.$80.6B$27.00
- LZAGYLonza Group AG$49.1B$69.02
- WXIBFWuXi Biologics (Cayman) Inc.$29.5B$7.13
- SDMHFSartorius Stedim Biotech S.A.$23.5B$242.02
- GNNSFGenscript Biotech Corporation$11.4B$5.20
- RGENSELLRepligen Corporation$9.8BBEARQ 26$173.88+1.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TWST?
- LOPJLB’s latest quantitative signal on Twist Bioscience Corporation (TWST) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TWST in?
- Twist Bioscience Corporation (TWST) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Twist Bioscience Corporation (TWST) do?
- Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed…